Dose Error Leaves Lasting Scars – Then This

Doctor using tablet beside hospital patient — Photo: Pressmaster / Shutterstock

A Georgia woman says a routine antibiotic triggered new burns and swelling years after a documented drug reaction left her skin blistered and peeling.

Story Highlights

Court records and news reports document a 2014 Stevens-Johnson syndrome diagnosis after lamotrigine.
The woman spent weeks in a medically induced coma and suffered lasting injuries.
In 2025, she reported facial swelling after amoxicillin for a tooth infection.
Stevens-Johnson syndrome is rare but linked to several medicines, including lamotrigine.

Documented 2014 Crisis Tied To Lamotrigine Dosing

Georgia appellate records state that an expert linked a 2014 life-threatening rash to incorrect titration of lamotrigine, known by the brand Lamictal, with a diagnosis of Stevens-Johnson syndrome. The court summarized testimony that the severe reaction was avoidable and tied to dosing decisions, giving legal weight to the medical account. Local and national reports at the time also described widespread blistering and skin loss after the medicine exposure, and they identified Stevens-Johnson syndrome as the diagnosis.

Coverage from the period reported that the woman endured a prolonged hospitalization, including a medically induced coma lasting over a month, and emerged with significant scarring and disability. One national outlet reported a five-week coma and detailed the burn-unit level care that followed. These accounts match the clinical severity seen in confirmed Stevens-Johnson syndrome cases, where rapid treatment and withdrawal of the trigger drug can be life-saving.

Reported 2025 Reaction After Dental Antibiotic

A 2025 report says the same woman sought dental care for an infected tooth and was prescribed amoxicillin. She reported taking six doses over two days, then developed facial swelling and irritation of the eyes and mouth lining, prompting urgent concern. The article quotes her saying she warned the dentist about her past drug reaction, while the dentist treated that history as an allergy and proceeded with the antibiotic prescription, according to her account.

The 2025 article provides a clear timeline from prescription to symptoms, but it does not present a hospital record confirming a new Stevens-Johnson syndrome diagnosis. The described swelling and mucosal irritation are warning signs that deserve immediate evaluation, yet the available report does not include a clinician’s formal diagnosis, biopsy, or discharge summary for that episode. Readers should note this limit on the public record while recognizing that her earlier 2014 diagnosis is well documented by court and media sources.

How Rare Drug Reactions Turn Deadly Fast

Doctors know Stevens-Johnson syndrome and toxic epidermal necrolysis as rare but severe reactions most often linked to medicines. A meta-analysis found that about 23 percent of cases in the included studies were connected to antiepileptic drugs, with lamotrigine a known contributor within that group. Separate clinical literature estimates that serious skin loss syndromes occur in a small fraction of lamotrigine users, even as milder rashes are more common among patients on the drug.

Researchers and clinicians have also warned that rapid dose increases can raise the risk for dangerous eruptions with lamotrigine. Medical reports describe higher risk with fast titration schedules, which is why careful ramp-up is standard practice when starting the drug. These findings echo the expert testimony cited in the Georgia case, which focused on dose titration as a key factor in the 2014 outcome. The lesson is simple: dosing discipline and clear patient warnings can prevent tragedy.

Accountability, Informed Consent, And Patient Autonomy

Patients deserve plain-language risk warnings, accurate allergy records, and conservative prescribing when a history of severe reactions exists. The 2014 case shows how a dosing error can spiral into catastrophic harm, long hospital stays, and lifelong scars. The 2025 report underscores another point: when a patient reports a severe past reaction, prescribers should pause, verify records, and consider alternatives or urgent specialist input rather than default to routine antibiotics, especially when symptoms could escalate quickly.

What Readers Should Watch For Next

Clear documentation answers key questions. For the 2014 crisis, court records and news reports already show a confirmed diagnosis, a dose-related error, and devastating injury. For the 2025 dental episode, the public account describes an alarming sequence but does not include a clinical diagnosis in the shared record. Future updates that include hospital charts, physician notes, and test results would help define the exact nature and cause of the 2025 symptoms.